Sigrid Therapeutics inks major manufacturing deal with Japan’s AGC for SiPore15[®]
Targeting $10 billion prediabetes/obesity market with unique fat/carbohydrate uptake reducing product Stockholm, Sweden, June 2, 2021. Sweden’s Sigrid Therapeutics, which has been developing a unique concept for preventing two of the world’s greatest health challenges, diabetes and obesity, has taken a great leap towards a product launch by signing an agreement on collaboration with the Japanese company AGC Si-Tech. Meanwhile, the company’s CEO, Sana Alajmovic, has both been named one of the Female Leaders of the Future and won the Life Science category of the Nova 111 list. Two of